| Authors: |
Gashaw IA; Experimental Medicine Cardiovascular, Renal and Metabolic, Boehringer Ingelheim Pharma GmbH & Co. KG, 55216 Ingelheim am Rhein, Germany., Tuttle KR; Providence Medical Research Center, Providence Inland Northwest Health, Spokane, WA 99204, United States.; Division of Nephrology and Kidney Research Institute, University of Washington, Seattle, WA 98195, United States., Monroy Kuhn M; Experimental Medicine Biomarker Platforms, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a. d. Riss, Germany., Pleiner S; Experimental Medicine Biomarker Platforms, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a. d. Riss, Germany., Delic D; Experimental Medicine Biomarker Platforms, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a. d. Riss, Germany.; Vth Department of Medicine, University Medical Center Mannheim, Heidelberg University, 68167 Heidelberg, Germany., Cronin L; Global Clinical Development Cardiovascular, Renal and Metabolic, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, United States., Shah SV; Global Clinical Development Cardiovascular, Renal and Metabolic, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, United States., Rossing P; Department of Clinical and Translational Research, Steno Diabetes Center Copenhagen, 2730 Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark. |
